Abstract
Chordomas are rare, slow-growing malignant tumors. Given the paucity of data of the disease, the treatment strategies are disputed. We collected clinical and survival information of patients with chordoma diagnosed between 1975 and 2016 from the Surveillance, Epidemiology, and End Results database. A total of 1797 patients were initially enrolled, including 762 (42.4%) cranial and 1035 (57.6%) spinal chordoma. A total of 1504 patients were further evaluated after screening. In the cranial group, the surgery (gross total resection (GTR): p = 0.001 for overall survival (OS); p = 0.009 for cancer-specific survival (CSS)), tumor extension (distant metastasis: p = 0.001 for OS; p = 0.002 for CSS), and the age (p < 0.001 for OS) were independent prognostic factors for survival. In the spinal group, the age (p = 0.004), location (p < 0.001), GTR (p < 0.001), and tumor extension (distant metastasis, p < 0.001) were independent prognostic factors for OS; the age (p = 0.007), histological type (p < 0.001), GTR (p < 0.001), radiation (p = 0.018), chemotherapy (p = 0.006), and tumor extension (p < 0.001) were independent prognostic factors for CSS. In this large cohort, a significant association was noted between extent of resection and outcome. Even though adjuvant radiation or chemotherapy did not benefit patients with chordoma, the effect on prognosis can be explored in a further study based on our findings.
Similar content being viewed by others
Code availability
R software.
References
Bergh P, Kindblom LG, Gunterberg B, Remotti F, Ryd W, Kindblom JMM (2000) Prognostic Factor in Chordoma of Sacrum and Mobile Spine. Cancer-am Cancer Soc 88:2122–34
Bugoci DM, Girvigian MR, Chen JC, Miller MM, Rahimian J (2013) Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas. Am J Clin Oncol 36:404–10
Brian P, Walcott A, Brian V, Nahed A, Ahmed M (2012) Chordoma: current concepts, management, and future directions. Lancet Oncol 13:e69-76
Chordoma: Natural history and treatment results in 33 cases (1988) Chordoma: Natural history and treatment results in 33 cases. J Surg Oncol 37:185–91
Coffin CM, Swanson PE, Wick MR, Dehner LP (1993) Chordoma in childhood and adolescence. A clinicopathologic analysis of 12 cases. Arch Pathol Lab Med 117:927–933
Kerekes D, Rory Goodwin C, Karim Ahmed A, Verlaan J-J (2019) Local and Distant Recurrence in Resected Sacral Chordomas: A Systematic Review and Pooled Cohort Analysis. Global Spine J 9:191–201
Fletcher CDM BJ, Hogendoorn PCW, Mertens F (2013) WHO Classification of Tumours of Soft Tissue and Bone. IARC S, Lyon, FR, pp 327–328
Frezza AM, Botta L, Trama A, Tos APD, Stacchiotti S (2018) Chordoma: update on disease, epidemiology, biology and medical therapies. Curr Opin Oncol 31:114–120
Goodarzi A, Toussi A, Lechpammer M, Lee D, Shahlaie K (2017) Intradural chordoma of the cerebellopontine angle: case report and review. World Neurosurg 107:1052.e11-1052.e16
Heffelfinger MJ, Dahlin DC, Maccarty CS, Beabout JW (1973) Chordomas and cartilaginous tumors at the skull base. Cancer-Am Cancer Soc 32:410–420
Hsieh PC, Xu R, Sciubba DM, Mcgirt MJ, Gokaslan ZL (2009) Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas: a series of twenty consecutive patients. Spine 34:2233–2239
Hsieh PC, Xu R, Sciubba DM, Mcgirt MJ, Nelson C, Witham TF, Wolinksy JP, Gokaslan ZL (2009) Long-term clinical outcomes following en bloc resections for sacral chordomas and chondrosarcomas. Spine 34:2233–2239
Jawad MU, Scully SP (2010) Surgery significantly improves survival in patients with chordoma. Spine 35:117–123
Lee IJ, Lee RJ, Fahim DK (2017) Prognostic Factors and Survival Outcomes in Patients with Chordoma in the United States: A Population-Based Analysis. World Neurosurg 104:346–355
Mcmaster ML, Goldstein AM, Bromley CM, Parry IDM (2001) Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes & Control Ccc 12:1
Multicenter Phase II Trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas (2009) Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. J Clin Oncol 27:3154-3160
Rassi MS, Maher HM, Kaith A, Bi WL, Svetlana P, Dunn IF, Smith TR, Ossama AM (2017) Pediatric Clival Chordoma: A Curable Disease that Conforms to Collins’ Law. Neurosurgery 82:652–660
Rotondo RL, Folkert W, Liebsch NJ, Chen YE, Pedlow FX, Schwab JH, Rosenberg AE, Nielsen GP, Szymonifka J, Ferreira AE (2015) High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine 23:788–97
Sahyouni R, Goshtasbi K, Mahmoodi A, Chen JW (2018) A historical recount of chordoma. J Neurosurg Spine 28:422–428
Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Kel OJ, Edler L, Scholz M, Debus J (2007) Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol 68:449–457
Sibley RK, Day DL, Dehner LP, Trueworthy RC (1987) Metastasizing chordoma in early childhood: a pathological and immunohistochemical study with review of the literature. Pediatr Pathol 7:287–301
Spiro IJ (1999) Sacral chordoma: 40-year experience at a major cancer center. Neurosurgery 44:80
Spjut HJ, Luse SA (1964) Chordoma: an electron microscopic study. Cancer-Am Cancer Soc 17:643–656
Stacchiotti S, Casali PG, Vullo SL, Mariani L, Palassini E, Mercuri M, Alberghini M, Pilotti S, Zanella L, Gronchi A (2010) Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol 17:211–219
Tzortzidis F, Elahi F, Wright DC, Temkin N, Natarajan SK, Sekhar LN (2006) Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 58:1090–1098
Wagner TD, Kobayashi W, Dean S, Goldberg SI, Kirsch DG, Suit HD, Hornicek FJ, Pedlow FX, Raskin KA, Springfield DS (2009) Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone. Int J Radiat Oncol Biol Phys 73:259–266
Yagiz Yolcu, Waseem Wahood, Mohammed Ali, Alvi Panagiotis, Kerezoudis Scott (2019) Evaluating the Role of Adjuvant Radiotherapy in Management of Sacral and Vertebral Chordoma: Results from a National Database. World Neurosurg 127:e1137–e1144
Yasuda M, Bresson D, Chibbaro S, Cornelius JF, Polivka M, Feuvret L, Takayasu M, George B (2012) Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients. Neurosurg Rev 35:171–183
Yoneoka Y, Tsumartuma I, Fukuda M, Tamura T, Morii K, Tanaka R, Fujii Y (2008) Cranial base chordoma – long term outcome and review of the literature. Acta Neurochirurgica -Wien- 150:773–778
Author information
Authors and Affiliations
Contributions
Conception and experimental design: all authors.
Acquisition of data: all authors.
Analysis and interpretation of data: all authors.
Drafting the article: Gui-Jun Zhang and Yu-Shi Cui.
Statistical analysis: Gui-Jun Zhang and Yu-Shi Cui.
Approved the final version of the manuscript on behalf of all authors: Huan Li.
Corresponding author
Ethics declarations
Ethics approval
This study was approved by the Institutional Review Board.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, GJ., Cui, YS. & Li, H. Survival and treatment of cranial and spinal chordomas: a population-based study. Neurosurg Rev 45, 637–647 (2022). https://doi.org/10.1007/s10143-021-01583-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10143-021-01583-5